Therefore, the study evaluated the level of gal-3 in patients with DCM and found that the abnormal elevation of gal-3 level indicated a greater risk of MACEs, which proved that gal-3 had significant predictive value for MACEs in DCM. The gene discussed is LGALS3; the disease is familial dilated cardiomyopathy.